ZW-38

N/A

Report date: 2026/03/19 20:00:18

Base Information

Drug NameZW-38

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionImmunomodulatorsCD3 T-cell engagersAnti-CD19

TargetsT cell surface glycoprotein CD3B-lymphocyte antigen CD19

Therapy Area/IndicationsLymphomaLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesZymeworks Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesZymeworks Inc

Active IndicationsN/A

Inactive IndicationsLymphomaLeukemia

Other Information

ATC CodeN/A